Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Cancers|May 27, 2026
Chronic IFN-γ Exposure Induces Divergent Adaptive Programs in Glioblastoma SubtypesElnaz Rahbarlayegh, Natsuko Nomura, Tiffany M Juarez, et al.Bioelectronic Medicine|April 9, 2024
Evaluation of the EMulate Therapeutics Voyager's ultra-low radiofrequency energy in murine model of glioblastomaRajesh Mukthavaram, Pengfei Jiang, Sandra Pastorino, et al.Journal of Translational Medicine|July 10, 2025
Multimodal evaluation of cerebrospinal fluid from breast cancer leptomeningeal metastases using circulating tumor cell detection, single-cell sequencing, and proteomicsElnaz Rahbarlayegh, Alexandre Wojcinski, Natsuko Nomura, et al.Neuro-Oncology Advances|July 25, 2025
Phase II trial of nilotinib in PDGFR-alpha-enriched recurrent high-grade gliomasDavid Piccioni, Tiffany M Juarez, Sneha L Kesari, et al.Journal of Translational Medicine|October 20, 2017
A novel small molecule inhibitor of p32 mitochondrial protein overexpressed in gliomaVenkata Yenugonda, Natsuko Nomura, Valentina Kouznetsova, et al.Kekkaku : [Tuberculosis]|December 5, 2013
[A case of tuberculosis that occurred during treatment of hepatocellular carcinoma with sorafenib]Yusuke Kobayashi, Masahito Emura, Takaya Nakamura, et al.Annals of Translational Medicine|May 21, 2015
Hyaluronan expression in primary and secondary brain tumorsLaurence Jadin, Sandra Pastorino, Rebecca Symons, et al.Neuro-Oncology Advances|October 28, 2024
A phase 1 dose escalation of pritumumab in patients with refractory or recurrent gliomas or brain metastasesJose Carrillo, Jaya Mini Gill, Charles Redfern, et al.Oncotarget|July 28, 2016
Anti-cancer effects of nitrogen-containing bisphosphonates on human cancer cellsPengfei Jiang, Peiying Zhang, Rajesh Mukthavaram, et al.Human Antibodies|October 18, 2017
Pritumumab, the first therapeutic antibody for glioma patientsIvan Babic, Elmar Nurmemmedov, Venkata M Yenugonda, et al.Pageof 4